title: A 5' promoter region SNP in NRG1 is associated with schizophrenia risk and type III isoform expression.
authors.forename: K K
authors.initials: KK
authors.lastname: Nicodemus
authors.forename: A J
authors.initials: AJ
authors.lastname: Law
authors.forename: A
authors.initials: A
authors.lastname: Luna
authors.forename: R
authors.initials: R
authors.lastname: Vakkalanka
authors.forename: R E
authors.initials: RE
authors.lastname: Straub
authors.forename: J E
authors.initials: JE
authors.lastname: Kleinman
authors.forename: D R
authors.initials: DR
authors.lastname: Weinberger
mesh_terms: D000328:Adult; D000704:Analysis of Variance; D016022:Case-Control Studies; D005260:Female; D020022:Genetic Predisposition to Disease; D006624:Hippocampus / Q000378:metabolism*; D006801:Humans; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D020890:Neuregulin-1 / Q000235:genetics* / Q000378:metabolism; D020641:Polymorphism, Single Nucleotide; D011401:Promoter Regions, Genetic; D020033:Protein Isoforms / Q000235:genetics / Q000378:metabolism; D012333:RNA, Messenger / Q000032:analysis; D012016:Reference Values; D012307:Risk Factors; D012559:Schizophrenia / Q000235:genetics* / Q000378:metabolism; D035781:Siblings
chemical_list: C094131:NRG1 protein, human; D020890:Neuregulin-1; D020033:Protein Isoforms; D012333:RNA, Messenger